Who will bid....no idea...the question and only question is what will they do with the patent. Do they continue with costly and lengthy pharmaceutical indications that very few (if any) on this board will see come to market? Or, will they recognize the changing political winds and reintroduce Anatabloc to a friendly FDA as an anti inflammatory that served 10's of thousands.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.